Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter. Looking at the volume ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $13.0 to $26.5 for Pfizer over the last 3 months.

To get a sense of who is truly in control of Pfizer Inc. (NYSE:PFE), it is important to understand the ownership structure of ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Just as U.S. households were fretting about the effect on travel and the wider economy of the longest-ever government ...

Michael Burry shorts Nvidia and Palantir, stoking AI bubble fears. Scion’s $1.1B puts shake markets. NVDA and PLTR rally over ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Risky assets slid, with tech stocks and cryptocurrencies bearing the brunt of the selling, after long-simmering concerns ...

Asian stocks were set to gain Tuesday, tracking advances on Wall Street as Amazon.com Inc.’s $38 billion deal with OpenAI reignited enthusiasm for artificial-intelligence shares.

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...